Mark V. Sherrid
Impact in
-
- Cardiomyopathy and Myosin Studies
- Cardiovascular Function and Risk Factors
- Cardiovascular Effects of Exercise
- Viral Infections and Immunology Research
- Cardiac pacing and defibrillation studies
- Cardiac Arrhythmias and Treatments
- Developmental Neuroscience top 5%
Papers in
-
- Cardiomyopathy and Myosin Studies 127
- Cardiovascular Function and Risk Factors 40
- Cardiovascular Effects of Exercise 29
- Cardiac pacing and defibrillation studies 12
- Takotsubo Cardiomyopathy and Associated Phenomena 11
- Viral Infections and Immunology Research 10
- Epidemiology 20
- Congenital Heart Disease Studies 14
- Co-authors
- Daniel G. Swistel (29 shared papers)Barry J. Maron (17 shared papers)Farooq A. Chaudhry (15 shared papers)David Z. Gunsburg (4 shared papers)Sandhya K. Balaram (9 shared papers)Martin S. Maron (12 shared papers)Ethan J. Rowin (9 shared papers)Milind Y. Desai (10 shared papers)
- Journals
- Journal of the American College of Cardiology (32 papers)Journal of the American Society of Echocardiography (12 papers)Journal of the American Heart Association (11 papers)The American Journal of Cardiology (9 papers)Progress in Cardiovascular Diseases (7 papers)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Mark V. Sherrid
161 papers receiving 7.9k citations
Mark V. Sherrid's Hit Papers
Peers
Comparison fields: 5 of 111
- Cardiology and Cardiovascular Medicine 7.3k
- Developmental Neuroscience 146
- Epidemiology 988
- Surgery 936
- Radiology, Nuclear Medicine and Imaging 432
Countries citing papers authored by Mark V. Sherrid
This map shows the geographic impact of Mark V. Sherrid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark V. Sherrid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark V. Sherrid more than expected).
Fields of papers citing papers by Mark V. Sherrid
This network shows the impact of papers produced by Mark V. Sherrid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark V. Sherrid. The network helps show where Mark V. Sherrid may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark V. Sherrid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 173 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2020 | 845 |
| 2 | Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy Hit paper breakdown → | 2007 | 629 |
| 3 | Diagnosis and Evaluation of Hypertrophic Cardiomyopathy Hit paper breakdown → | 2022 | 360 |
| 4 | 2005 | 313 | |
| 5 | Management of Hypertrophic Cardiomyopathy Hit paper breakdown → | 2022 | 257 |
| 6 | Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy Hit paper breakdown → | 2020 | 254 |
| 7 | Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity Hit paper breakdown → | 2021 | 243 |
| 8 | 2019 | 234 | |
| 9 | 2000 | 226 | |
| 10 | 2003 | 226 | |
| 11 | 2016 | 196 | |
| 12 | 2020 | 174 | |
| 13 | 2005 | 171 | |
| 14 | 1990 | 163 | |
| 15 | 2015 | 152 | |
| 16 | 1993 | 141 | |
| 17 | 2003 | 138 | |
| 18 | 2013 | 138 | |
| 19 | 1998 | 135 | |
| 20 | 2014 | 127 |
About Mark V. Sherrid
Mark V. Sherrid is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology, Surgery, Radiology, Nuclear Medicine and Imaging and Emergency Medicine, having authored 173 papers that have together received 8.4k indexed citations. Recurring topics across this work include Cardiomyopathy and Myosin Studies (127 papers), Cardiovascular Function and Risk Factors (40 papers), Cardiovascular Effects of Exercise (29 papers), Cardiac Structural Anomalies and Repair (23 papers), Congenital Heart Disease Studies (14 papers), Cardiac pacing and defibrillation studies (12 papers), Takotsubo Cardiomyopathy and Associated Phenomena (11 papers) and Viral Infections and Immunology Research (10 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (7.3k citations), Developmental Neuroscience (146 citations), Epidemiology (988 citations), Surgery (936 citations) and Radiology, Nuclear Medicine and Imaging (432 citations). Mark V. Sherrid has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Daniel G. Swistel, Barry J. Maron, Farooq A. Chaudhry, David Z. Gunsburg, Sandhya K. Balaram, Martin S. Maron, Ethan J. Rowin, Milind Y. Desai, Bette Kim and Glenda Winson. Their work appears in journals such as Journal of the American College of Cardiology, Journal of the American Society of Echocardiography, Journal of the American Heart Association, The American Journal of Cardiology and Progress in Cardiovascular Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.